Option chain shows key data for Medincell's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Medincell.

Medincell (OTC:MDCLF) Stock, Option Chain

Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Biotech

News

Penny Stocks

Health Care

Small Cap

Movers

Trading Ideas

General

ALVR

ARCT

MDCLF

NAVB

OTIC

TEVA

WINT

Here&#39;s a roundup of top developments in the biotech space over the last 24 hours.

The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus&#39; COVID-19 Vaccine Trial Data, FDA Rejects Teva&#39;s Schizophrenia Med, Otonomy Aces Hearing Loss Study

FDA Rejects Teva - MedinCell&#39;s Schizophrenia Candidate

Medincell SA

Medincell

Comments

Medincell

Medincell (MDCLF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell